Becton, Dickinson and Co. | BDX - Capital De Empréstimo

Preço das Ações
155.40
Mudança Diária
-1.69 -1.08%
Mensal
-5.17%
Anual
-21.96%
Q2 Previsão
149.86




Capital De Empréstimo Alterar Data
Abbott USD 9.9B 1.7B 2025-12
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
AngioDynamics USD 5.6M 100K 2025-09
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cooper Companies USD 1.88B 578.5M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Globus Medical USD 436K 9K 2025-12
Hologic USD 2.5B 2.1M 2025-12
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 39.44B 30M 2025-12
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Solventum Corp USD 5.04B 102M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Terumo JPY 99.9B 12M 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12